GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OptiBiotix Health PLC (FRA:OB3) » Definitions » EV-to-FCF

OptiBiotix Health (FRA:OB3) EV-to-FCF : -8.34 (As of Apr. 05, 2025)


View and export this data going back to 2018. Start your Free Trial

What is OptiBiotix Health EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, OptiBiotix Health's Enterprise Value is €16.46 Mil. OptiBiotix Health's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 was €-1.97 Mil. Therefore, OptiBiotix Health's EV-to-FCF for today is -8.34.

The historical rank and industry rank for OptiBiotix Health's EV-to-FCF or its related term are showing as below:

FRA:OB3' s EV-to-FCF Range Over the Past 10 Years
Min: -57.93   Med: -26.01   Max: -4.47
Current: -8.96

During the past 13 years, the highest EV-to-FCF of OptiBiotix Health was -4.47. The lowest was -57.93. And the median was -26.01.

FRA:OB3's EV-to-FCF is ranked worse than
100% of 440 companies
in the Biotechnology industry
Industry Median: 2.895 vs FRA:OB3: -8.96

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-04-05), OptiBiotix Health's stock price is €0.171. OptiBiotix Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was €-0.037. Therefore, OptiBiotix Health's PE Ratio (TTM) for today is At Loss.


OptiBiotix Health EV-to-FCF Historical Data

The historical data trend for OptiBiotix Health's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OptiBiotix Health EV-to-FCF Chart

OptiBiotix Health Annual Data
Trend Jul12 Nov14 Nov15 Nov16 Nov17 Nov18 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -45.71 -39.87 -22.34 -8.64 -15.56

OptiBiotix Health Semi-Annual Data
May14 Nov14 May15 Nov15 May16 Nov16 May17 Nov17 May18 Nov18 May19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -8.64 - -15.56 -

Competitive Comparison of OptiBiotix Health's EV-to-FCF

For the Biotechnology subindustry, OptiBiotix Health's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OptiBiotix Health's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OptiBiotix Health's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where OptiBiotix Health's EV-to-FCF falls into.


;
;

OptiBiotix Health EV-to-FCF Calculation

OptiBiotix Health's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=16.455/-1.973
=-8.34

OptiBiotix Health's current Enterprise Value is €16.46 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. OptiBiotix Health's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 was €-1.97 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


OptiBiotix Health  (FRA:OB3) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

OptiBiotix Health's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.171/-0.037
=At Loss

OptiBiotix Health's share price for today is €0.171.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. OptiBiotix Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was €-0.037.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


OptiBiotix Health EV-to-FCF Related Terms

Thank you for viewing the detailed overview of OptiBiotix Health's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


OptiBiotix Health Business Description

Traded in Other Exchanges
Address
Innovation Centre, Innovation Way, Heslington, York, GBR, YO10 5DG
OptiBiotix Health PLC is engaged in the field of healthcare. As a life science company, its prime focus lies in researching the area of biotechnology. Its activities include the identification of microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that can impact human physiology, deriving potential health benefits. The company derives majority of the revenue from the sale of Functional Fibres. The company markets its products in the United Kingdom under trademark names such as OptiBiotix, SweetBiotix, and SkinBioTherapeutics.

OptiBiotix Health Headlines

No Headlines